Open
SectorHealthcare
3.66 -2.14
24h
Min
3.64
Max
3.79
Income | -11M -46M |
---|---|
Sales | -815K 4.2M |
EPS | -0.15 |
Profit margin | -1,077.237 |
Employees | 596 |
EBITDA | 16M -40M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +84.21% upside |
Next Earnings | 5 sie 2025 |
---|
Market Cap | 403M 1B |
---|---|
Previous open | 5.8 |
Previous close | 3.66 |
By Acuity
67%
33%
338 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 7 USD 84.21%
High 10 USD
Low 5 USD
Based on 5 Wall Street analysts offering 12 month price targets forAbCellera Biologics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$